University of Pittsburgh and Parallel, a Leading Cannabis Company, Join Forces in Pennsylvania Medical [Cannabis] Research Program
Parallel will provide $3 million in grant funding for clinical studies on sickle cell disease, anxiety, and other chronic illnesses;...
![University of Pittsburgh and Parallel, a Leading Cannabis Company, Join Forces in Pennsylvania Medical [Cannabis] Research Program](https://extractionmagazine.com/wp-content/uploads/2020/08/11d350f4e0eb54884fd3acdab9c0710a-350x250.jpg)

![McConnell Misleads on [Cannabis]](https://extractionmagazine.com/wp-content/uploads/2020/08/us-capitol-green-flag-350x250.jpg)


